X4 Pharmaceuticals, Inc (XFOR)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$253.1M
Stockholders' Equity
$155.5M
Cash & Equivalents
$195.1M
Long-Term Debt
$75.0M

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, X4 Pharmaceuticals, Inc reported revenue of $8.8M, net income of -$16.2M, and total assets of $253.1M. Every figure below is taken directly from X4 Pharmaceuticals, Inc's SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2018–FY2025 · as reported

$35.1M-$33.0M-$101.2M
FY2018FY2020FY2022FY2024FY2025
Revenue$35.1MNet income-$79.2M
FY2018 revenue
$0
FY2025 revenue
$35.1M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$35.1M-$79.2M
FY2024$2.6M-$37.5M
FY2023$0-$101.2M
FY2022$0-$93.9M
FY2021$0-$88.7M
FY2020$3.0M-$62.1M
FY2019$0-$52.8M
FY2018$0-$33.3M
FY2017—-$22.0M
FY2016—-$23.0M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 29, 2026on EDGAR ↗
8-KOct 8, 2026on EDGAR ↗
8-KSep 8, 2026on EDGAR ↗
8-KSep 8, 2026on EDGAR ↗
10-QAug 6, 2026on EDGAR ↗
8-KJul 1, 2026on EDGAR ↗
8-KMay 12, 2026on EDGAR ↗
10-QMay 6, 2026on EDGAR ↗
DEF 14AMar 20, 2026on EDGAR ↗
10-KMar 17, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$253.1Msource ↗
Stockholders’ Equity$155.5Msource ↗
Cash & Equivalents$195.1Msource ↗
Long-Term Debt$75.0Msource ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$8.8Msource ↗
Net Income-$16.2Msource ↗
Operating Income-$16.4Msource ↗
Gross Profit$7.2Msource ↗
Cost of Revenue$1.6Msource ↗
R&D Expense$15.1Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.13source ↗
EPS (basic)$-0.13source ↗
Shares Outstanding99.1Msource ↗
Cash from Operations-$20.8Msource ↗
Cash from Financing$75,000source ↗
Cash from Investing-$1.0Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
1
Sells
5
Net shares
-104.7K

Restatement history

Point-in-time

30 of 265 annual fact-keys were materially restated between filings: what X4 Pharmaceuticals, Inc first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches XFOR’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/XFOR

MCP tool: get_sec_fundamentals ticker=XFOR

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/XFOR/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=XFOR as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/XFOR/history

MCP tool: get_fundamentals_history ticker=XFOR

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/XFOR

MCP tool: get_financial_health ticker=XFOR

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.